Imunon, Inc.
IMNN
$6.24
-$0.11-1.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.23M | 2.17M | -9.41M | 3.29M | 2.82M |
| Gross Profit | -1.23M | -2.17M | 9.41M | -3.29M | -2.82M |
| SG&A Expenses | 1.54M | 1.98M | 1.91M | 1.67M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.77M | 4.15M | 4.15M | 4.96M | 5.01M |
| Operating Income | -2.77M | -4.15M | -4.15M | -4.96M | -5.01M |
| Income Before Tax | -2.74M | -4.10M | -4.06M | -4.85M | -4.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.74M | -4.10M | -4.06M | -4.85M | -4.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.74M | -4.10M | -4.06M | -4.85M | -4.79M |
| EBIT | -2.77M | -4.15M | -4.15M | -4.96M | -5.01M |
| EBITDA | -2.69M | -4.08M | -4.11M | -4.90M | -4.95M |
| EPS Basic | -1.87 | -3.68 | -3.64 | -4.38 | -6.64 |
| Normalized Basic EPS | -1.17 | -2.30 | -2.28 | -2.73 | -4.15 |
| EPS Diluted | -1.87 | -3.68 | -3.64 | -4.38 | -6.64 |
| Normalized Diluted EPS | -1.17 | -2.30 | -2.28 | -2.73 | -4.15 |
| Average Basic Shares Outstanding | 1.47M | 1.12M | 1.11M | 1.11M | 720.70K |
| Average Diluted Shares Outstanding | 1.47M | 1.12M | 1.11M | 1.11M | 720.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |